Eleva is exploring the potential of one of its drug candidates for first-in-line therapy of COVID-19. Read more...
Relief Therapeutics and its U.S. partner, NeuroRx, announced treatment of the first patients with RLF-100 at the University of Miami Miller School of Medicine, FL. Read more...